Retinopathy Of Prematurity Global Clinical Trials Review, H2, 2018

Retinopathy Of Prematurity Global Clinical Trials Review, H2, 2018

  • GlobalData
  • July 2018
  • Pharmaceutical
  • 90 pages
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Retinopathy Of Prematurity to Ophthalmology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Retinopathy Of Prematurity to Ophthalmology Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 25
In Progress Trials by Phase 26
Clinical Trials by Trial Status 27
Clinical Trials by End Point Status 29
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Retinopathy Of Prematurity Therapeutics Clinical Trials 34
Prominent Drugs 36
Clinical Trial Profile Snapshots 37
Appendix 88
Abbreviations 88
Definitions 88
Research Methodology 89
Secondary Research 89
About GlobalData 90
Contact Us 90
Disclaimer 90
Source 90

List of Tables
Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials by Region, 2018* 7
Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Retinopathy Of Prematurity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Retinopathy Of Prematurity Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Retinopathy Of Prematurity Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Retinopathy Of Prematurity Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
Retinopathy Of Prematurity Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
Proportion of Retinopathy Of Prematurity to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 17
Retinopathy Of Prematurity Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Retinopathy Of Prematurity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20
Proportion of Retinopathy Of Prematurity to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 22
Retinopathy Of Prematurity Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Retinopathy Of Prematurity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials by Phase, 2018* 25
Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 26
Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials by Trial Status, 2018* 28
Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
Retinopathy Of Prematurity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 31
Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 33
Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 35
Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36

List of Figures
Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Retinopathy Of Prematurity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Retinopathy Of Prematurity Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Retinopathy Of Prematurity Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Retinopathy Of Prematurity Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
Retinopathy Of Prematurity Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
Proportion of Retinopathy Of Prematurity to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 16
Retinopathy Of Prematurity Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Retinopathy Of Prematurity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Retinopathy Of Prematurity to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 21
Retinopathy Of Prematurity Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Retinopathy Of Prematurity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials by Phase (%), 2018* 25
Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 26
Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
Retinopathy Of Prematurity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 31
Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36
GlobalData Methodology 89

Have query on this report?

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074